Compumedics Ltd (CMP)

Currency in AUD
0.355
-0.005(-1.39%)
Closed·
CMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3550.355
52 wk Range
0.2400.420
Key Statistics
Bid/Ask
0.325 / 0.355
Prev. Close
0.355
Open
0.355
Day's Range
0.355-0.355
52 wk Range
0.24-0.42
Volume
5K
Average Volume (3m)
135.61K
1-Year Change
33.96%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.800
Upside
+125.35%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Compumedics Ltd Company Profile

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. Additionally, the company provides doppler diagnostic products; Nuevo LTM EEG; Orion LifeSpan MEG; and quik-cap EEG electrode arrays. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.

Compare CMP to Peers and Sector

Metrics to compare
CMP
Peers
Sector
Relationship
P/E Ratio
−55.9x−4.4x−0.6x
PEG Ratio
0.22−0.020.00
Price/Book
3.3x3.8x2.6x
Price / LTM Sales
1.4x6.1x3.3x
Upside (Analyst Target)
125.4%69.3%40.1%
Fair Value Upside
Unlock7.9%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.800
(+125.35% Upside)

Earnings

Latest Release
Sep 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
27.51M / --
EPS Revisions
Last 90 days

CMP Income Statement

FAQ

What Stock Exchange Does Compumedics Ltd Trade On?

Compumedics Ltd is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Compumedics Ltd?

The stock symbol for Compumedics Ltd is "CMP."

What Is the Compumedics Ltd Market Cap?

As of today, Compumedics Ltd market cap is 70.92M.

What Is Compumedics Ltd's Earnings Per Share (TTM)?

The Compumedics Ltd EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is CMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Compumedics Ltd Stock Split?

Compumedics Ltd has split 0 times.

How Many Employees Does Compumedics Ltd Have?

Compumedics Ltd has 175 employees.

What is the current trading status of Compumedics Ltd (CMP)?

As of 02 Dec 2025, Compumedics Ltd (CMP) is trading at a price of 0.355, with a previous close of 0.355. The stock has fluctuated within a day range of 0.355 to 0.355, while its 52-week range spans from 0.240 to 0.420.

What Is Compumedics Ltd (CMP) Price Target According to Analysts?

The average 12-month price target for Compumedics Ltd is AUD0.8, with a high estimate of AUD0.8 and a low estimate of AUD0.8. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +125.35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.